{
  "id": 7442207,
  "title": "Impact Biomedical corrects merger exchange ratio, sets reverse stock split",
  "url": "https://urgent.news/2026/09/15/impact-biomedical-corrects-merger-exchange-ratio-sets-reverse-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-15T01:32:33.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/impact-biomedical-corrects-merger-exchange-ratio-sets-reverse-stock-split-93CH-4900717"
  },
  "original_language": "en",
  "account": "Impact Biomedical Inc. (NYSE American: IBO) corrected its merger exchange ratio with Zoar Limited on Monday, according to a press release. The company clarified that stockholders will receive one Zoar share for each Impact share held prior to the merger's effective date, following a reverse stock split. A previous September 11 statement had incorrectly set the ratio at one Zoar share for every four Impact shares. The board approved a 1-for-12.62 reverse stock split, effective September 23 at 12:01 a.m. Eastern Time, as reported. This adjustment will occur while the stock continues trading on the NYSE American under ticker IBO. The reverse split, previously approved between 1-for-12.48 and 1-for-50 on December 30, 2025, will reduce shares from approximately 107.82 million to 8.54 million, rounding minor adjustments. No fractional shares will be issued, with excess rounded up. Equiniti Trust Company manages the share exchange, and no fractional shares will be issued.",
  "summary": null,
  "key_points": [
    "Impact Biomedical corrected merger exchange ratio with Zoar Limited.",
    "Stockholders to receive one Zoar share per Impact share post reverse stock split.",
    "1-for-12.62 reverse stock split effective September 23, reducing shares to 8.54 million."
  ],
  "editors_take": "The correction of the merger exchange ratio and implementation of a 1-for-12.62 reverse stock split changes the terms of Impact Biomedical's merger with Zoar Limited, affecting shareholder equity.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}